Jazz Pharmaceuticals (NasdaqGS:JAZZ) Q1 2026 Earnings call May 05, 2026 04:30 PM ET Company Participants John Bluth - Head of Investor Relations Philip Johnson - CFO Renée Gala - President and CEO Robert Iannone - Global Head of Research and Development and CMO Samantha Pearce - Chief Commercial Officer Conference Call Participants Ami Fadia - Analyst Annabel Samimy - Analyst Charlie Moore - Analyst David Amsellem - Analyst David Hoang - Analyst Jason Gerberry - Analyst Jessica Fye - Analyst Jordan Becker - ...